A detailed history of Neos Investment Management LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Neos Investment Management LLC holds 4,837 shares of CTLT stock, worth $293,847. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,837
Previous 4,025 20.17%
Holding current value
$293,847
Previous $226 Million 29.45%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$56.16 - $60.96 $45,601 - $49,499
812 Added 20.17%
4,837 $293 Million
Q2 2024

Aug 14, 2024

BUY
$53.58 - $57.02 $215,659 - $229,505
4,025 New
4,025 $226 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.9B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Neos Investment Management LLC Portfolio

Follow Neos Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neos Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neos Investment Management LLC with notifications on news.